Nuvation Bio’s Ibtrozi Gains FDA Approval: A New Hope for ROS1-Positive Lung Cancer Patients Amid Market Challenges June 12, 2025
Nuvation Bio’s Ibtrozi Receives FDA Approval: A Game-Changer for ROS1-Positive Lung Cancer Patients June 12, 2025
Ibtrozi: A Promising New Hope for ROS1-Positive Lung Cancer Patients Amidst Market Challenges June 12, 2025
SpliceBio Secures $135 Million to Revolutionize Gene Therapy for Stargardt Disease with Dual-Vector Technology June 11, 2025
SpliceBio Secures $135 Million to Revolutionize Gene Therapy for Stargardt Disease with Innovative Dual AAV Approach June 11, 2025
Antares Therapeutics Launches with $177 Million Funding to Advance Innovative Cancer Treatments June 11, 2025
Scorpion Therapeutics Spinoff Antares Therapeutics Secures $177 Million to Drive Innovative Cancer Drug Development June 11, 2025
Antares Therapeutics Launches with $177 Million Funding to Pursue Innovative Cancer Treatments June 11, 2025
Antares Therapeutics: A Promising New Frontier in Targeted Cancer Therapy Following Scorpion’s Success June 10, 2025
Antares Therapeutics: Charting New Frontiers in Cancer Treatment with $177 Million Launch June 10, 2025
